Showing results (251-260 of 266) with videos related to

Sort By:
Pageof 27
Cancer Science|June 1, 2021
Determination of brain tumor recurrence using 11 C-methionine positron emission tomography after radiotherapyShigeru Yamaguchi, Kenji Hirata, Michinari Okamoto, et al.
Annals of Nuclear Medicine|September 25, 2013
Prediction of outcomes in MCI with (123)I-IMP-CBF SPECT: a multicenter prospective cohort studyKengo Ito, Etsuro Mori, Hidenao Fukuyama, et al.
Medicine|September 29, 2020
Enhanced immune reaction resulting from co-vaccination of WT1 helper peptide assessed on PET-CTJun Nakata, Kayako Isohashi, Soyoko Morimoto, et al.
Metabolism: Clinical and Experimental|July 2, 2015
Myocardial energy provision is preserved by increased utilization of glucose and ketone bodies in CD36 knockout miceKazuhiro Nakatani, Tadashi Watabe, Daisaku Masuda, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 28, 2012
Clinical trial of the intratumoral administration of labeled DC combined with systemic chemotherapy for esophageal cancerShinichi Fujiwara, Hisashi Wada, Hiroshi Miyata, et al.
Journal of Neurosurgery|May 2, 2008
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiformeShuichi Izumoto, Akihiro Tsuboi, Yoshihiro Oka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2018
Japanese multicenter database of healthy controls for [123I]FP-CIT SPECTHiroshi Matsuda, Miho Murata, Yohei Mukai, et al.
Dementia and Geriatric Cognitive Disorders Extra|December 14, 2011
Different characteristics of cognitive impairment in elderly schizophrenia and Alzheimer's disease in the mild cognitive impairment stageHiroaki Kazui, Tetsuhiko Yoshida, Masahiko Takaya, et al.
Japanese Journal of Clinical Oncology|April 14, 2006
A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I dataSatoshi Morita, Yoshihiro Oka, Akihiro Tsuboi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 13, 2020
Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trialKatsumi Hirose, Akiyoshi Konno, Junichi Hiratsuka, et al.
Pageof 27